Investigating the effect of zinc supplementation on probability of relapse and mental health in patients with opioid use disorder undergoing methadone maintenance treatment
- PMID: 36609286
- PMCID: PMC9817328
- DOI: 10.1186/s13011-023-00514-5
Investigating the effect of zinc supplementation on probability of relapse and mental health in patients with opioid use disorder undergoing methadone maintenance treatment
Abstract
Background: Considering different factors, such as high withdrawal rates in methadone maintenance treatment (MMT) programs alongside mental health (MH) problems appearing in patients with opioid use disorder and the lack of prior research on the effect of zinc supplementation in this respect, the present study aimed to investigate the effect of zinc supplementation on the probability of relapse (PoR) and MH problems in patients with opioid use disorder undergoing MMT.
Methods: For this purpose, a randomized controlled trial with a clinical basis was fulfilled on a total of 68 patients with opioid use disorder receiving MMT, allocated to two groups, viz. intervention, and control (each one consisting of 34 individuals). Then, the participants in the intervention group were given zinc supplements combined with methadone for three months, and the controls only took methadone, according to the treatment plan. The data were collected using the Relapse Prediction Scale (RPS) and the Depression, Anxiety, and Stress Scale 21 (DASS-21) before, one month after, and at the end of the intervention program.
Findings: Compared to the control group, the likelihood of drug use (p = 0.01), drug craving (p = 0.002), and the RPS total score (p = 0.002) in the intervention group was significantly lower. Moreover, the results revealed a significant decreasing trend in depression (p = 0.01), anxiety (p < 0.001), stress (p = 0.001), and the DASS-21 total score (p = 0.001) in the intervention. Compared to the control group, the DASS-21 total score (p < 0.001) in the intervention group was significantly lower.
Conclusion: Accordingly, it was concluded that zinc supplementation could reduce the PoR and improve MH problems in patients with opioid use disorder experiencing MMT. However, further research is recommended to fill the gaps.
Trial registration: The research protocol has also been listed on the Iranian Registry of Clinical Trials (IRCT) with code no. IRCT2020050904736N1.
Keywords: Mental health; Methadone maintenance treatment; Probability of relapse; Zinc supplementation.
© 2023. The Author(s).
Conflict of interest statement
The authors did not declare any conflict of interest.
Figures
Similar articles
-
The effectiveness of Transcranial Photobiomodulation therapy (tPBM) on reducing anxiety, depression, and opioid craving in patients undergoing methadone maintenance treatment: a double-blind, randomized, controlled trial.BMC Psychiatry. 2025 Feb 3;25(1):94. doi: 10.1186/s12888-025-06555-3. BMC Psychiatry. 2025. PMID: 39901090 Free PMC article. Clinical Trial.
-
Multi-level predictors of psychological problems among methadone maintenance treatment patients in difference types of settings in Vietnam.Subst Abuse Treat Prev Policy. 2019 Sep 18;14(1):39. doi: 10.1186/s13011-019-0223-4. Subst Abuse Treat Prev Policy. 2019. PMID: 31533764 Free PMC article.
-
Impact of combination of intermittent theta burst stimulation and methadone maintenance treatment in individuals with opioid use disorder: A comparative study.Psychiatry Res. 2023 Sep;327:115411. doi: 10.1016/j.psychres.2023.115411. Epub 2023 Aug 11. Psychiatry Res. 2023. PMID: 37574603
-
Medication-assisted treatment with methadone: assessing the evidence.Psychiatr Serv. 2014 Feb 1;65(2):146-57. doi: 10.1176/appi.ps.201300235. Psychiatr Serv. 2014. PMID: 24248468 Review.
-
Correlates of methamphetamine use severity among patients receiving methadone maintenance treatment for opioid use disorder in Vietnam.J Subst Abuse Treat. 2022 Jan;132:108461. doi: 10.1016/j.jsat.2021.108461. Epub 2021 May 7. J Subst Abuse Treat. 2022. PMID: 34098204 Free PMC article. Review.
Cited by
-
Multi-ancestry genome-wide association meta-analysis of buprenorphine treatment response.Neuropsychopharmacology. 2025 Aug;50(9):1346-1353. doi: 10.1038/s41386-025-02117-z. Epub 2025 May 6. Neuropsychopharmacology. 2025. PMID: 40328918 Free PMC article.
References
-
- Le TA, Le MQT, Dang AD, Dang AK, Nguyen CT, Pham HQ, et al. Multi-level predictors of psychological problems among methadone maintenance treatment patients in difference types of settings in Vietnam. Subst Abuse Treat Prev Policy. 2019;14(1):1–10. doi: 10.1186/s13011-019-0223-4. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical